Summary The expression of Group-TI phospholipase A2 (M-PLA2) was analysed immunohistochemically in malignant, non-malignant (including atrophic, hyperplastic, pseudopyloric metaplastic and intestinal metaplastic) and normal human gastric mucosae. M-PLA2 was consistently detected in the stem cell lineage, pseudopyloric metaplasia and the generative cells of hyperplastic foveolar epithelium and intestinal metaplasia (IM). In IM, the appearance of Phospholipase A2 (PLA2) catalyses the specific hydrolysis of a fatty acyl ester bond at the sn-2 position of glycerophospholipids. In addition, a calcium-dependent PLA2 is thought to be one of the most important enzymes regulating the release of arachidonic acid from membrane phospholipids (Lands, 1968; Van den Bosh, 1980). Until recently, two genetically distinct isoenzymes, exocrine PLA2 (secreted in pancreatic juice) and intracellular PLA2 (contained in the cytosol and membrane-associated fraction), have been recognised in humans (Vadas & Pruzanski, 1986; Nakaguchi et al., 1986) . In the membrane fraction of human spleen cells the existence of a PLA2, which does not react with anti-human P-PLA2 antibody, has been demonstrated (Nakaguchi et al., 1986) . Further purification and subsequent sequencing of this enzyme revealed that it belongs to the Group-I1 PLA2 (Kanda et al., 1989) . Group-II PLA2 has been thought to play an important regulatory role in several metabolic pathways (Nakano et al., 1990a; Nakano et al., 1990b) . And recently, the distribution of this Group-II-PLA2 in human organs has been published (Kiyohara et al., 1992) .
pseudopyloric metaplasia and the generative cells of hyperplastic foveolar epithelium and intestinal metaplasia (IM). In IM, the appearance of M-PLA2 was found to be closely related to the degree of development of the brush borders on columnar cells and was especially prominent at dense brush borders. Paneth cells of IM, particularly their secretory products, were strongly immunoreactive for M-PLA2. In gastric cancer, the expression of M-PLA2 was detected exclusively in cancer cells with a low grade of differentiation, and seemed to be intensified in the invading zone of the tumour. These observations suggest that the expression of M-PLA2 is associated with the proliferative kinetics and regeneration of human gastric mucosa, and may indicate a physiological relationship between its expression and metaplasia of small intestinal type. Moreover, the appearance of M-PLA2 may be related to the invasive ability of gastric cancer.
Phospholipase A2 (PLA2) catalyses the specific hydrolysis of a fatty acyl ester bond at the sn-2 position of glycerophospholipids. In addition, a calcium-dependent PLA2 is thought to be one of the most important enzymes regulating the release of arachidonic acid from membrane phospholipids (Lands, 1968; Van den Bosh, 1980) . Until recently, two genetically distinct isoenzymes, exocrine PLA2 (secreted in pancreatic juice) and intracellular PLA2 (contained in the cytosol and membrane-associated fraction), have been recognised in humans (Vadas & Pruzanski, 1986; Nakaguchi et al., 1986) . In the membrane fraction of human spleen cells the existence of a PLA2, which does not react with anti-human P-PLA2 antibody, has been demonstrated (Nakaguchi et al., 1986) . Further purification and subsequent sequencing of this enzyme revealed that it belongs to the Group-I1 PLA2 (Kanda et al., 1989) . Group-II PLA2 has been thought to play an important regulatory role in several metabolic pathways (Nakano et al., 1990a; Nakano et al., 1990b) . And recently, the distribution of this Group-II-PLA2 in human organs has been published (Kiyohara et al., 1992) .
The product of this enzyme's action, free arachidonate (which serves as a substrate for the cyclo-oxygenase route and lipoxygenase route) (Van den Bosh, 1980) is the first and rate-limiting precursor in the biosynthes of prostaglandins (PG), leukotriene and HETE (Lands, 1979; Van den Bosh, 1980) . Among these products, PG is abundant in gastrointestinal mucosa (Robert et al., 1979) , and especially PGE2, has potent cytoprotective effects, e.g. inhibition of gastric secretion, prevention of ulcer formation, and acceleration of the healing of mucosal damage (Robert et al., 1979; Wilson et al., 1971; Robert et al., 1976) . Nevertheless, the biological significance and function of PLA2 in the human stomach is still unknown. In the rat gastric mucosa, PLA2 which is structurally identical to the rat pancreatic type PLA2 (P-PLA2, Group-I PLA2) (Tojo et al., 1988; Okamoto et al., 1985) was immunocytochemically detected in chief cells (Tatsumi et al., 1990) . Knowledge of the distribution of this enzyme in human gastric mucosa might provide useful insight into the function of PLA2 in gastric mucosa.
In this study, the immunohistochemical expression of M-PLA2 was examined by using a monoclonal antibody (MoAb) against the recently described human splenic Group-II PLA2 (M-PLA2) in a variety of human gastric mucosae, such as normal, atrophic, hyperplastic, pseudopyloric metaplastic and intestinal metaplastic mucosae, as well as cancerous lesions. Moreover, the possible biological role of M-PLA2 is discussed, especially concerning the relationship between its expression and the cell-and tissue-kinetics of gastric mucosa.
Materials and methods

Tissues
Primary gastric cancers were obtained from 45 surgical specimens of gastrectomised patients. These patients consisted of 27 males and 18 females. Their ages ranged from 32 to 85 years old (average age 66.2 years). Tissues were fixed in 10% buffered formaldehyde for 4 days and embedded in paraffin. One of the serial sections from each tissue was stained with hematoxylin and eosin (H&E) for routine histologic examination, and the others were treated for the demonstration of M-PLA2 as described below. In the 45 specimens examined, normal foveolar epithelia of the cardia, fundus, and antrum were found in two, nine and two cases, respectively. Normal glands of cardia, fundus and antrum were also found in two, six and two cases, respectively. Moreover, normal duodenal mucosae in four cases were also studied.
Classification of intestinal metaplastic mucosa (IM)
Intestinal metaplastic changes in gastric mucosa near and/or adjacent to cancerous lesions were found in 32 cases. Since IM changes were often variable even within a single specimen, the intestinal metaplastic ducts were classified into three groups, according to the degree of development of the brush border on columnar cells (Morson, 1955; Murata et al., 1992) . Thus, IMs containing densely, sparsely or undeveloped brush borders were observed in 14, 10 and 20 sites, respectively, in 32 cases.
Classification ofgastric cancer
Gastric cancers were morphologically classified into six types according to the General Rules for the Gastric Cancer Study of the Japanese Research Society for Gastric Cancer (Japanese Research Society for Gastric Cancer, 1985) ; papillary adenocarcinoma (pap), tubular adenocarcinomas of the Monoclonal antibody (MoAb) The MoAb anti-M-PLA2 (IgG) employed was raised in mice immunised against M-PLA2 purified from the membranefraction of human spleens (Matsuda et al., 1991) .
Avidin-biotin-peroxidase complex method ABC kits (Vector Laboratories, Inc. USA) for mouse IgG were used. Formalin-fixed and paraffin-embedded tissue sections were deparaffinised with xylene and rehydrated with a series of ethanol solutions. Tissue sections were incubated in normal serum for 30 min following the block of endogenous peroxidase activity with 1% H202 in methanol for 20 min, incubated overnight at 4°C with optimally diluted primary MoAb, and subsequently incubated with biotinylated antimouse IgG and avidin-biotin peroxidase complex for 30 min at room temperature. They were washed in 0.01 M phosphate-buffered saline (PBS, pH 7.2) between each incubation step. The peroxidase reaction was applied using 0.01% 3,3'-diaminobenzidine tetrahydrochloride (Sigma: St Louis, MO, USA) in 0.05 M Tris-HCI buffer (pH 7.6). Sections were counterstained with Mayer's hematoxylin. For the negative control, the following procedures were employed: (1) sections were processed without the primary antibody, and (2) mouse IgG (M9144, Sigma: St Louis, MO, USA) was used instead of the primary antibody.
Results
The distribution of the M-PLA2-immunoreactive cells in human gastric and duodenal mucosa is summarised in Table I. Normal gastric and duodenal mucosa M-PLA2 was not expressed in the normal foveolar epithelia of two cardiac, nine fundic, and two antral mucosae. Similarly, M-PLA2 was not detected in two cardiac, six fundic, and two antral proper glands.
In four normal duodenal mucosae, the foveolar epithelia in all four specimens and Brunner's glands in two specimens expressed this antigen (Figure 1) . Furthermore, almost all Paneth cells at the bottom of these crypts expressed M-PLA2 in all four specimens. The expression of M-PLA2 in foveolar epithelia and Brunner's glands were found in Golgi and cytoplasmic pattern, respectively. In Paneth cells, positive staining in a fine granular pattern was seen among the eosinophilic granules but not in the cytoplasm. In a few cases, mucous neck cells, which are localised to an isthmus of gastric mucosa, were found to faintly express this antigen in cytoplasmic granular pattern (Figure 2 ).
Atrophic mucosa and pseudopyloric metaplasia Three fundic and one antral epithelia exhibiting atrophic changes were found not to express M-PLA2. Similarly, the atrophic glands of 16 fundic and two antral mucosae were also negative.
Pseudopyloric metaplasia, which appears as one of the regenerative forms following mucosal damage from gastritis or ulceration, was observed in 26 cases, and in 22 (84.6%) cases, M-PLA2 was expressed in Golgi pattern (Figure 3) . Furthermore, M-PLA2 appeared in Golgi pattern in 12 out of 14 (85.7%) cases with cystic degeneration of the pseudopyloric glands.
Hyperplastic mucosa Hyperplasia of the foveolar epithelia in the fundus and antrum was observed in two and one case, respectively, and the expression of M-PLA2 was seen in one fundic epithelium in the Golgi region. At the isthmus of this positive mucosa, which is postulated to be the generative zone of this hyperplastic epithelium, a strong immunoreactivity in Golgi or cytoplasmic granular pattern was observed ( Figure 4a ). As for hyperplasia of the proper glands, M-PLA2 was not expressed in three fundic nor one antral mucosae. with pseudopyloric metaplasia. The stain is distributed in a Golgi pattern. This pattern was also seen in epithelia exhibiting an absorptive-type metaplasia as well as in cystic degeneration of the pseudopyloric glands. The 'ABC' method described in the text was used. Bar = 100 gm.
Generative zone When regenerative transformation occurs following mucosal damage caused by gastritis, erosion, and ulceration, elongation of the generative zone, which consists of generative cells, is known to occur (Wright et al., 1990) . In this study, an apparent generative zone was found in 20 cases, and M-PLA2 was demonstrated in 16 (80.0%) cases in Golgi or cytoplasmic granular pattern (Figure 4b ). M-PLA2 was often detected in Golgi or cytoplasmic granular pattern at the bottom of the negative intestinal metaplastic ducts as well as above the generative zone (Figure 4c ).
Intestinal metaplastic ducts and Paneth cells
In IM near and/or adjacent to cancerous lesions, the frequency of the expression of M-PLA2 in crypts with densely, sparsely and undeveloped brush borders was 14/14 (100%), 6/10 (60.0%) and 0/20 (0%) sites, respectively. All the positive staining of the columnar cells occurred in Golgi pattern. Moreover, at dense brush borders, the manifest appearance of M-PLA2 was often demonstrated (Figure 5a ). On the other hand, all of the goblet cells were negative.
Twenty-two cases of those with intestinal metaplastic ducts had Paneth cells at and/or near the bottom of their crypts. Twenty (87.0%) cases exhibited positive staining, and M-PLA2 expression was observed not in the cytoplasm but among the many secretory granules, as well as in the duodenal mucosa ( Figure Sb) . Table II , the frequency of M-PLA2 expression was inversely proportional to the degree of cell-differentiation. The expression of this antigen was negative in seven papillary adenocarcinomas. Positive staining was found in one out of eight (12.5%) well differentiated tubular adenocarcinomas (tub,) (Figure 6a differentiated adenocarcinomas (por) and the moderately differentiated tubular adenocarcinomas (tub2). Positive staining in por and tub2 was found in eight out of 11 (72.7%) and four out of ten (40.0%) cases, respectively, and their staining pattern was cytoplasmic granular (Figure 6b ). The expression of M-PLA2 seemed to be more pronounced in the invasive areas of the tumour (Figure 6c ). On the other hand, cancer cells capable of producing mucin, such as signet-ring cell carcinoma (sig) and mucinous adenocarcinoma (muc), generally failed to stain with the monoclonal antibody, although a few sig cells which were interspersed among por faintly expressed M-PLA2-
Cancerous tissues As shown in
Discussion
In the present study, the expression of M-PLA2 was analysed immunohistochemically in malignant and non-malignant mucosae (including atrophic, hyperplastic, pseudopyloric metaplastic and intestinal metaplastic), as well as normal mucosa of the human stomach.
In normal gastric mucosa, M-PLA2 was expressed in neither foveolar epithelia nor proper glands, except for mucous neck cells which are thought to be generative cells (stem cells) in gastric mucosa (MacDonald et al., 1964) . In contrast, the elongated zone of stem cells, which appears following a breach in the gastrointestinal mucosa (Wright et al., 1990) , strongly expressed M-PLA2 in the same pattern. Similarly, the isthmus in hyperplastic foveolar epithelia, which is postulated to be its generative zone, exhibited significant M-PLA2 expression. In intestinal metaplasia, M-PLA2 was expressed in cells at the bottom of the glands, differing from the Paneth cells found in M-PLA2-negative metaplastic ducts. Since the generative cells in IM have been reported to be localised at the bottom of the ducts, these positive cells were thought to be identical with generative cells of IM (Hattori & Fujita, 1979; Poulsen et al., 1986) . Furthermore, pseudopyloric glands, which signify gastric regeneration (Hashimoto et al., 1983) , frequently expressed this enzyme. These results suggest an association of the presence of M-PLA2 with cell proliferative kinetics and regeneration of gastric mucosa. Moreover, it is tempting to postulate that the increased expression of PLA2, stemming from a mucosal accident or age-related changes, results in the increased biosynthesis of prostaglandins which protects the gastric mucosa and accelerates the healing of the mucosa damage (Robert et al., 1979; Wilson et al., 1971; Robert et al., 1976) . M-PLA2 was frequently expressed in IM. However, IM is not a single entity but rather variable by a number of criteria including morphologic (Morson, 1955) , enzymatic (Shimada et al., 1987) , and mucin histochemical studies (Segura & Montero, 1983) . For example, small and large intestinal types (or complete and incomplete) have been described. In this study, IM was morphologically classified into three groups, according to the degree of development of the brush border. We found a positive association between the expression of M-PLA2 and the extent of development of the brush border, and dense brush borders often had substantial positive staining. In a separate study, we found that M-PLA2 was distributed in the normal human digestive tract mainly in small intestine in a pattern similar to that seen in IM. It was not detected in the large intestine. This suggests that the cells in the metaplastic ducts expression M-PLA2 are physiologically related to those in the normal small intestine which express M-PLA2. Therefore, the results in this study may (SenagasBalas et al., 1984) . Since the Paneth cell is postulated to secrete substances affecting the growth and differentiation of intestinal epithelia (Poulsen et al., 1986) , the expression of M-PLA2 might be related to cell proliferation not only in the normal intestine but also in IM.
In addition, the secretory granules in the Paneth cells of germ-free mammalian small intestine have been reported to change subsequent to the administration of bacteria (Satoh, 1988) . This hints that Paneth cells play some role in the regulation of the bacterial milieu in the small intestine. It has been previously demonstrated that there is no crossimmunoreactivity between pancreatic and intestinal phospholipase in rat Paneth cells (Erlandsen & Case, 1972) . Therefore, these results suggest that the cell membrane of bacteria could be denatured by M-PLA2 expressed in Paneth cells and the bacterial milieu might be regulated in the small intestine and also in the complete type of IM. Moreover, the hydrolysis catalysed by M-PLA2 may be a necessary step for the phagocytosis of bacteria (Matsukura et al., 1979) .
In a separate study, we found that M-PLA2 was expressed in the foetal but not the adult gastric mucosa (Kiyohara et al., 1992) . Therefore, the abundant expression of M-PLA2 in undifferentiated cancer cells supports the hypothesis that the presence of this enzyme may be related to cell-and/or tissuedifferentiation of gastric mucosa. The expression of M-PLA2 in cancer was inversely proportional to the degree of the carcinoma's cell-differentiation. Particularly intense staining was seen in invasive gastric cancer as well as poorly differentiated adenocarcinoma (por). The staining was most pronounced at the invading zone near the centre of the cancerous tissue. These results suggest that poorly differentiated cancer cells may require the hydrolysis catalysed by M-PLA2 to infiltrate into uninvolved and adjacent tissues.
IM has been recognised as a precursor of gastric cancer by a number of morphologic (Morson, 1955) , enzymatic (Shimada et al., 1987) , mucin histochemical (Segura & Montero, 1983) , and experimental studies (Matsukura, 1979) . This is especially true of the apparent relationship between differentiated cancer, such as pap and tub,, and the large intestinal (incomplete) type of IM Shimada et al., 1987) . In contrast, there have been few reports concerning the precursors of undifferentiated gastric cancer. In the present study, M-PLA2 was absent in both most of differentiated cancers and the incomplete type of IM lacking Paneth cells and a brush border. However, it was strongly positive in both undifferentiated cancer and in the generative cells of the stomach. Undifferentiated por cancer (but not sig) is thought to originate from the undifferentiated cell zone of the non-metaplastic mucosa (Hattori, 1985) . Therefore, these results indicate that the generative cells may be the precursor cells of undifferentiated gastric cancer.
Since Levine et al. (1977) first reported the release of PGE2
and PGF,4 from renal cells stimulated by epidermal growth factor (EGF), it has been demonstrated that various cytokines, e.g. EGF (Nolan et al., 1988) , tumour necrosis factor (Hori et al., 1989) and interleukin-l (Dayer et al., 1990 ) stimulate PLA2-activity and induce the synthesis of certain prostaglandins which regulate cell mitogenesis. Therefore, the growth of M-PLA2-positive cancer cells, especially those which are undifferentiated might be regulated by prostaglandins via the activation of M-PLA2. Additionally, since some kinds of fibroblasts have been reported to proliferate in response to prostaglandins (Nolan et al., 1988; Handler et al., 1990) , prostaglandins induced by M-PLA2-activation could accelerate the growth of interstitial tissue, resulting in the scirrhous changes usually observed in advanced undifferentiated cancer. Furthermore, M-PLA2 itself could be directly related to growth and differentiation in the human gastrointestinal tract, since P-PLA2 was recently reported to be a growth factor (Arita et al., 1991) .
